These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34452886)

  • 1. Down-Regulation of HBXIP Inhibits Non-Small Cell Lung Cancer Growth and Enhances the Anti-Tumor Immunity of Mice by Reducing NRP-1.
    Wang L; Sun M; Lin X; Lei Y; Yin Z; Zhou W
    Ann Clin Lab Sci; 2021 Jul; 51(4):487-493. PubMed ID: 34452886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
    Zhang J; Sun B; Ruan X; Hou X; Zhi J; Meng X; Zheng X; Gao M
    Cancer Biol Med; 2021 Feb; 18(1):105-119. PubMed ID: 33628588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
    Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z
    Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 8. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
    Li K; Jiang Y; Xiang X; Gong Q; Zhou C; Zhang L; Ma Q; Zhuang L
    Thorac Cancer; 2020 May; 11(5):1180-1190. PubMed ID: 32147945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
    Wang M; Wang W; Ding J; Wang J; Zhang J
    Thorac Cancer; 2020 Feb; 11(2):379-388. PubMed ID: 31841274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
    Yu L; Chen D; Song J
    Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m
    Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
    Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival.
    Grun D; Adhikary G; Eckert RL
    Mol Carcinog; 2019 Apr; 58(4):488-499. PubMed ID: 30456845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPV1 inhibition suppresses non-small cell lung cancer progression by inhibiting tumour growth and enhancing the immune response.
    Wang Y; Zhang Y; Ouyang J; Yi H; Wang S; Liu D; Dai Y; Song K; Pei W; Hong Z; Chen L; Zhang W; Liu Z; Mcleod HL; He Y
    Cell Oncol (Dordr); 2024 Jun; 47(3):779-791. PubMed ID: 37902941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
    Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
    Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells.
    Yan J; Zhang D; Han Y; Wang Z; Ma C
    J Cell Biochem; 2019 Oct; 120(10):17303-17311. PubMed ID: 31106485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
    Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
    Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis.
    Li Y; Zhang J; Pan S; Zhou J; Diao X; Liu S
    Thorac Cancer; 2020 Mar; 11(3):537-548. PubMed ID: 31917898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
    Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
    Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y
    Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIMD1-AS1 suppressed non-small cell lung cancer progression through stabilizing LIMD1 mRNA via hnRNP U.
    Pan J; Tang Y; Liu S; Li L; Yu B; Lu Y; Wang Y
    Cancer Med; 2020 Jun; 9(11):3829-3839. PubMed ID: 32239804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.